FLFudong Liu

Fudong Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fudong Liu has a total of 78 co-authors. Here are the top co-authors by number of shared publications:

  • Abdullah Al Mamun

    Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA

    13 shared publications
  • Conelius Ngwa

    Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston

    13 shared publications
  • Romana Sharmeen

    Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, USA

    11 shared publications
  • Shaohua Qi

    Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, USA

    10 shared publications
  • Yan Xu

    Department of Neurology The University of Texas Health Science Center at Houston, McGovern Medical School Houston Texas USA

    10 shared publications
  • Louise D. McCullough

    Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, USA

    9 shared publications

Latest Publications

  • Open Access

    Microglial Transmembrane 119 (Tmem119) is Protective in Ischemic Stroke

    by Afzal Misrani, Yan Xu, Jingjing Wang, Eric A. Tanifum, Louise D. McCullough, Fudong Liu, Conelius Ngwa

    Microglial responses to cerebral ischemia are tightly regulated by inhibitory pathways that limit excessive post‐stroke inflammation. Transmembrane protein 119 (Tmem119) has emerged as an important regulator of microglial activation and neuroinflammatory signaling. We investigated the role of microglial Tmem119 during acute ischemic stroke using primary microglia and a young adult mouse model. Primary microglia were transfected with Tmem119‐siRNA and subjected to oxygen–glucose deprivation (OGD) alone or combined with lipopolysaccharide (LPS) stimulation. In vivo, young adult male mice received stereotaxic injection of lenti‐Tmem119 or lenti‐GFP for 4 weeks before 60 min of transient middle cerebral artery occlusion (MCAO). Tmem119 expression and inflammatory responses were assessed by qPCR, Western blotting, and ELISA at 1 and 3 days after stroke. Infarct volume and neurobehavioral outcomes were also evaluated. Tmem119 silencing significantly increased IRAK4, IRF5, and CD68 mRNA expression in primary microglia. Ischemic injury reduced microglial Tmem119 protein expression and increased IRAK4 signaling in vivo. In contrast, lenti‐Tmem119 treatment before MCAO decreased phosphorylated IRAK4 protein expression and increased IL‐10 levels in both plasma and ischemic brain tissue compared with lenti‐GFP controls. Tmem119 overexpression also significantly reduced infarct volume and improved neurobehavioral outcomes. These findings demonstrate that microglial Tmem119 exerts a protective anti‐inflammatory role during the acute phase of ischemic stroke by suppressing IRAK4‐mediated inflammatory signaling and enhancing IL‐10 production. Collectively, Tmem119 limits microglial activation, reduces ischemic brain injury, and improves functional recovery, identifying Tmem119 as a promising therapeutic target for ischemic stroke.

  • Open Access

    Perspective Chapter: Epigenetic Modifications in Stroke – Molecular Mechanisms and Therapeutic Targets

    by Afzal Misrani, Shaohua Qi, Conelius Ngwa, Fudong Liu

    In recent years, research on epigenetic modifications has expanded rapidly, highlighting their crucial role in regulating gene expression. This area of study emphasizes how epigenetic mechanisms guide natural evolutionary processes and preserve distinct gene expression profiles in mammals. Unlike genetics, which focuses on DNA sequences, epigenetics examines changes to genetic information beyond DNA sequence alterations. Numerous studies have investigated the link between epigenetic changes and central nervous system (CNS) disorders, providing insights into the complex nature of these modifications in such conditions. This review specifically explores epigenetic changes in stroke, emphasizing their impact on disease onset and progression. Additionally, it discusses sex differences in different types of epigenetic modifications. Furthermore, the review surveys the development of epigenetics-based therapeutic strategies for stroke. By leveraging our growing understanding of epigenetic mechanisms, researchers aim to pioneer new approaches for stroke treatment and prevention, offering promising avenues for improving patient outcomes and reducing the burden of this devastating disease.

  • Open Access

    Mitochondrial dysfunction in Alzheimer's disease and related sex differences

    by Afzal Misrani, Conelius Ngwa, Fudong Liu

    Alzheimer's disease (AD), the most common form of dementia, accounts for 70% of cases and remains a major healthcare challenge due to its rising prevalence and lack of disease-modifying treatments. Clinically, AD is a sexually dimorphic disease. Women exhibit more rapid cognitive decline and accelerated brain atrophy during mild cognitive impairment and early dementia, whereas men more frequently present cardiovascular comorbidities, earlier mitochondrial dysfunction, and greater neuropsychiatric symptoms. AD is marked by amyloid-β (Aβ) plaques, neurofibrillary tangles, neuroinflammation, and neuronal loss, with mitochondrial dysfunction emerging as a key early contributor that exhibits sex specific phenotypes. Mitochondria are vital for neuronal function by generating ATP, maintaining calcium homeostasis, and regulating oxidative stress. However, mitochondria in AD exhibit impaired ATP synthesis, excessive reactive oxygen species (ROS) production, calcium dysregulation, and disrupted fission-fusion dynamics. AD mitochondrial dysfunction can be measured by molecular markers, such as increased expression of fission-related protein Drp1, decreased biogenesis regulator PGC-1α, and elevated oxidative stress markers like malonaldehyde, nitotyrosine and protein carbonyls. Accumulating data suggest that sex differences in mitochondrial dysfunction are attributed to either sex hormonal or sex chromosomal effects, which eventually contribute to sex dichotomic phenotypes of AD. This review collected data regarding mitochondrial dysfunction in AD, with an emphasis on sex differences in oxidative stress, energy metabolism, and regulatory pathways.


  • Open Access

    Peripheral CD200R signaling: A critical regulator of post-stroke inflammation in aged mice

    by Conelius Ngwa, Afzal Misrani, Yan Xu, Jingjing Wang, Rodney Ritzel, Fudong Liu


  • Escape of Kdm6a from X Chromosome Is Detrimental to Ischemic Brains via IRF5 Signaling

    by Conelius Ngwa, Afzal Misrani, Kanaka Valli Manyam, Yan Xu, Shaohua Qi, Romana Sharmeen, Juneyoung Lee, Long-Jun Wu, Louise McCullough, Fudong Liu

    The role of chromatin biology and epigenetics in disease progression is gaining increasing recognition. Genes that escape X chromosome inactivation (XCI) can impact neuroinflammation through epigenetic mechanisms. Our previous study has suggested that the X escapee genes Kdm6a and Kdm5c are involved in microglial activation after stroke in aged mice. However, the underlying mechanisms remain unclear. We hypothesized that Kdm6a/5c demethylate H3K27Me3/H3K4Me3 in microglia, respectively, and mediate the transcription of interferon regulatory factor 5 (IRF5) and IRF4, leading to microglial pro-inflammatory responses and exacerbated stroke injury. Aged (17–20 months) Kdm6a/5c microglial conditional knockout (CKO) female mice (one allele of the gene) were subjected to a 60-min middle cerebral artery occlusion (MCAO). Gene floxed females (two alleles) and males (one allele) were included as controls. Infarct volume and behavioral deficits were quantified 3 days after stroke. Immune responses including microglial activation and infiltration of peripheral leukocytes in the ischemic brain were assessed by flow cytometry. Epigenetic modification of IRF5/4 by Kdm6a/5c was analyzed by CUT&RUN assay. The demethylation of H3K27Me3 by kdm6a increased IRF5 transcription; meanwhile, Kdm5c demethylated H3K4Me3 to repress IRF5. Both Kdm6afl/fl and Kdm5cfl/fl mice had worse stroke outcomes compared to fl/y and CKO mice. Gene floxed females showed more robust expression of CD68 in microglia and elevated brain and plasma levels of IL-1β or TNF-α, after stroke. We concluded that IRF5 signaling plays a critical role in mediating the deleterious effect of Kdm6a, whereas Kdm5c’s effect is independent of IRF5.


  • Retracted
    Open Access

    RETRACTED: Brain endothelial CD200 signaling protects brain against ischemic damage

    by Afzal Misrani, Conelius Ngwa, Abdullah Al Mamun, Romana Sharmeen, Kanaka Valli Manyam, Rodney M. Ritzel, Louise McCullough, Fudong Liu


  • Central IRF4/5 Signaling Are Critical for Microglial Activation and Impact on Stroke Outcomes

    by Conelius Ngwa, Abdullah Al Mamun, Shaohua Qi, Romana Sharmeen, Maria P. Blasco Conesa, Bhanu P. Ganesh, Bharti Manwani, Fudong Liu

    Microglia and monocytes play a critical role in immune responses to cerebral ischemia. Previous studies have demonstrated that interferon regulatory factor 4 (IRF4) and IRF5 direct microglial polarization after stroke and impact outcomes. However, IRF4/5 are expressed by both microglia and monocytes, and it is not clear if it is the microglial (central) or monocytic (peripheral) IRF4-IRF5 regulatory axis that functions in stroke. In this work, young (8–12 weeks) male pep boy (PB), IRF4 or IRF5 flox, and IRF4 or IRF5 conditional knockout (CKO) mice were used to generate 8 types of bone marrow chimeras, to differentiate the role of central (PB-to-IRF CKO) vs. peripheral (IRF CKO-to-PB) phagocytic IRF4-IRF5 axis in stroke. Chimeras generated from PB and flox mice were used as controls. All chimeras were subjected to 60-min middle cerebral artery occlusion (MCAO) model. Three days after the stroke, outcomes and inflammatory responses were analyzed. We found that PB-to-IRF4 CKO chimeras had more robust microglial pro-inflammatory responses than IRF4 CKO-to-PB chimeras, while ameliorated microglial response was seen in PB-to-IRF5 CKO vs. IRF5 CKO-to-PB chimeras. PB-to-IRF4 or IRF5 CKO chimeras had worse or better stroke outcomes respectively than their controls, whereas IRF4 or 5 CKO-to-PB chimeras had similar outcomes compared to controls. We conclude that the central IRF4/5 signaling is responsible for microglial activation and mediates stroke outcomes.


  • Open Access

    Regulation of microglial activation in stroke in aged mice: a translational study

    by Conelius Ngwa, Abdullah Al Mamun, Shaohua Qi, Romana Sharmeen, Yan Xu, Fudong Liu

    Numerous neurochemical changes occur with aging and stroke mainly affects the elderly. Our previous study has found interferon regulatory factor 5 (IRF5) and 4 (IRF4) regulate neuroinflammation in young stroke mice. However, whether the IRF5-IRF4 regulatory axis has the same effect in aged brains is not known. In this study, aged (18-20-month-old), microglial IRF5 or IRF4 conditional knockout (CKO) mice were subjected to a 60-min middle cerebral artery occlusion (MCAO). Stroke outcomes were quantified at 3d after MCAO. Flow cytometry and ELISA were performed to evaluate microglial activation and immune responses. We found aged microglia express higher levels of IRF5 and lower levels of IRF4 than young microglia after stroke. IRF5 CKO aged mice had improved stroke outcomes; whereas worse outcomes were seen in IRF4 CKO vs. their flox controls. IRF5 CKO aged microglia had significantly lower levels of IL-1β and CD68 than controls; whereas significantly higher levels of IL-1β and TNF-α were seen in IRF4 CKO vs. control microglia. Plasma levels of TNF-α and MIP-1α were decreased in IRF5 CKO vs. flox aged mice, and IL-1β/IL-6 levels were increased in IRF4 CKO vs. controls. The anti-inflammatory cytokines (IL-4/IL-10) levels were higher in IRF5 CKO, and lower in IRF4 CKO aged mice vs. their flox controls. IRF5 and IRF4 signaling drives microglial pro- and anti-inflammatory response respectively; microglial IRF5 is detrimental and IRF4 beneficial for aged mice in stroke. IRF5-IRF4 axis is a promising target for developing new, effective therapeutic strategies for the cerebral ischemia.


  • X, but not Y, Chromosomal Complement Contributes to Stroke Sensitivity in Aged Animals

    by Shaohua Qi, Conelius Ngwa, Abdullah Al Mamun, Sharmeen Romana, Ting Wu, Sean P. Marrelli, Arthur P. Arnold, Louise D. McCullough, Fudong Liu

    Post-menopausal women become vulnerable to stroke and have poorer outcomes and higher mortality than age-matched men, and previous studies suggested that sex chromosomes play a vital role in mediating stroke sensitivity in the aged. It is unknown if this is due to effects of the X or Y chromosome. The present study used the XY* mouse model (with four genotypes: XX and XO gonadal females and XY and XXY gonadal males) to compare the effect of the X vs. Y chromosome compliment in stroke. Aged (18–20 months) and gonadectomized young (8–12 weeks) mice were subjected to a 60-min middle cerebral artery occlusion. Infarct volume and behavioral deficits were quantified 3 days after stroke. Microglial activation and infiltration of peripheral leukocytes in the aged ischemic brain were assessed by flow cytometry. Plasma inflammatory cytokine levels by ELISA, and brain expression of two X chromosome–linked genes, KDM6A and KDM5C by immunochemistry, were also examined. Both aged and young XX and XXY mice had worse stroke outcomes compared to XO and XY mice, respectively; however, the difference between XX vs. XXY and XO vs. XY aged mice was minimal. Mice with two copies of the X chromosome showed more robust microglial activation, higher brain-infiltrating leukocytes, elevated plasma cytokine levels, and enhanced co-localization of KDM6A and KDM5C with Iba1+ cells after stroke than mice with one X chromosome. The number of X chromosomes mediates stroke sensitivity in aged mice, which might be processed through the X chromosome–linked genes and the inflammatory responses.